Joseph Gardner

President and Chief Executive Officer
biopharmaceutical
Aerpio Pharmaceuticals
United States of America

Business Expert Plant Sciences
Biography

 Dr. Gardner was the founding CEO of Akebia Therapeutics, Inc. in 2007, following twenty-three years of pharmaceutical discovery and development work at Procter & Gamble Pharmaceuticals. As CEO of Akebia, Joseph completed four rounds of private financing and moved the lead anemia drug, AKB-6548, successfully through Phase 2 studies in humans. In March of 2014, Akebia Therapeutics raised over $100M in a public offering and is now a publicly traded company on the NASDAQ. Joseph founded Aerpio as a spin out from Akebia Therapeutics, Inc in December of 2011 bringing over the Tie2 and HIF-1 activator programs.

Research Intrest

 pharmaceutical